ClinicalTrials.gov
public full text
Public Domain
Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients
This study will compare placebo to 4 different doses of SBR759 to assess the phosphate lowering efficacy in dialysis patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia#1152525
- A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP#1075715
- A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia#891250
- A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia#1096863
- The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients#851169
Record · ID 903217
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive